Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Brain Neoplasms 22Carcinoma, Non-Small-Cell Lung 17Pancreatic Neoplasms 11Neoplasm Metastasis 11Prostatic Neoplasms 9Melanoma 9Lung Neoplasms 9Glioblastoma 8Breast Neoplasms 8Carcinoma, Hepatocellular 7Squamous Cell Carcinoma of Head and Neck 6Glioma 6Carcinoma, Renal Cell 6Neoplasms 5Colorectal Neoplasms 5Head and Neck Neoplasms 4Uveal Melanoma 3Oligodendroglioma 3Liver Neoplasms 3Gliosarcoma 3Astrocytoma 3Adenocarcinoma 3Vulvar Neoplasms 2Vaginal Neoplasms 2Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Small Cell Lung Carcinoma 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2Laryngeal Neoplasms 2

Interventions

pembrolizumab 6Cisplatin 6Magnetic Resonance Spectroscopy 5Specimen Handling 4Radiotherapy 3Radiation 3Nivolumab 3Fluorouracil 3Biopsy 3Surveys and Questionnaires 2Radiosurgery 2Paclitaxel 2Chemoradiotherapy 2Cetuximab 22-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a 2zimberelimab 1toripalimab 1temsirolimus 1peposertib 1nabiximols 1motexafin gadolinium 1mogamulizumab 1ipatasertib 1dl1520 1camrelizumab 1brodalumab 1belinostat 1apatinib 1advexin 1Valproic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Mouth Neoplasms × Radiosurgery × Clear all
NCT07156227 2026-06-03

Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma

National Cancer Institute (NCI)

Phase 1 Recruiting
39 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

NCT04576091 2024-12-13

Testing the Addition of an Anti-cancer Drug, BAY 1895344, With Radiation Therapy to the Usual Pembrolizumab Treatment for Recurrent Head and Neck Cancer

National Cancer Institute (NCI)

Phase 1 Active not recruiting
7 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms, Salivary Gland Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡